Seguir
Walter Curran
Walter Curran
Chief of Piedmont Oncology Institute
Dirección de correo verificada de piedmont.org
Título
Citado por
Citado por
Año
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
29802014
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews, CB Scott, PW Sperduto, AE Flanders, LE Gaspar, ...
The Lancet 363 (9422), 1665-1672, 2004
29352004
Lung cancer: current therapies and new targeted treatments
FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ...
The Lancet 389 (10066), 299-311, 2017
28702017
National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1–3, 2000
National Institutes of Health Consensus Development Panel
JNCI Monographs 2001 (30), 5-15, 2001
2214*2001
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
A Aupérin, C Le Péchoux, E Rolland, WJ Curran, K Furuse, P Fournel, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2010
21582010
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …
JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...
The lancet oncology 16 (2), 187-199, 2015
20312015
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
WJ Curran Jr, CB Scott, J Horton, JS Nelson, AS Weinstein, AJ Fischbach, ...
JNCI: Journal of the National Cancer Institute 85 (9), 704-710, 1993
15531993
Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410
WJ Curran Jr, R Paulus, CJ Langer, R Komaki, JS Lee, S Hauser, ...
Journal of the National Cancer Institute 103 (19), 1452-1460, 2011
13932011
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ...
Journal of clinical oncology 31 (3), 337, 2013
12472013
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database
PW Sperduto, B Berkey, LE Gaspar, M Mehta, W Curran
International Journal of Radiation Oncology* Biology* Physics 70 (2), 510-514, 2008
11622008
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
A Trotti, R Byhardt, J Stetz, C Gwede, B Corn, K Fu, L Gunderson, ...
International Journal of Radiation Oncology* Biology* Physics 47 (1), 13-47, 2000
11222000
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
10672013
Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma
JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ...
New England Journal of Medicine 374 (14), 1344-1355, 2016
10162016
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and …
W Sause, P Kolesar, S Taylor IV, D Johnson, R Livingston, R Komaki, ...
Chest 117 (2), 358-364, 2000
9082000
Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group …
E Shaw, R Arusell, B Scheithauer, J O’fallon, B O’neill, R Dinapoli, ...
Journal of Clinical Oncology 20 (9), 2267-2276, 2002
8802002
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group …
G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ...
J Clin Oncol 24 (18), 2707-2714, 2006
8632006
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG …
JR Simpson, J Horton, C Scott, WJ Curran, P Rubin, J Fischbach, ...
International Journal of Radiation Oncology* Biology* Physics 26 (2), 239-244, 1993
7001993
Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable stage III NSCLC: RTOG 9410
WJ Curran Jr
Proc Am Soc Clin Oncol 22, 621, 2003
6912003
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial
CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ...
Journal of clinical oncology 22 (1), 157-165, 2004
6782004
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with …
L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ...
International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004
6722004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20